Sponsor Pipeline

Phenomen Pharma Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT07068191 Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) Recruiting
Disease Areas
NASH / MASH (1)
Get alerts when Phenomen Pharma's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free